These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
|
|
(4)
|
Proposed maximum aggregate value of transaction.
|
|
|
|
(5)
|
Total fee paid:
|
|
|
|
(1)
|
Amount Previously Paid:
|
|
|
|
(2)
|
Form, Schedule, or Registration Statement No.:
|
|
|
|
(3)
|
Filing Party:
|
|
|
|
(4)
|
Date Filed.
|
|
|
|
1.
|
To elect the seven trustees nominated and recommended by the Board of Trustees, each to serve until the 2020 Annual Meeting of Shareholders or until such time as their respective successors are elected and qualified;
|
|
2.
|
To hold an advisory vote on executive compensation;
|
|
3.
|
To hold an advisory vote on whether an advisory vote on executive compensation should be held every one, two or three years;
|
|
4.
|
To ratify the appointment of PricewaterhouseCoopers LLP to serve as our independent registered public accounting firm for the year ending December 31, 2019; and
|
|
5.
|
To transact such other business, if any, properly brought before the meeting.
|
|
|
|
|
|
Q.
|
How will we solicit proxies for the Annual Meeting?
|
|
A.
|
We are soliciting proxies by mailing this Proxy Statement and proxy card to our shareholders. In addition to solicitation by mail, some of our trustees and officers and certain employees of EMG may make additional solicitations by telephone or in person without additional compensation for such activities. We will pay the solicitation costs and will reimburse banks, brokerage houses and other custodians, nominees and fiduciaries for their reasonable expenses in forwarding proxy materials to beneficial owners.
|
|
Q.
|
Who is entitled to vote?
|
|
A.
|
All shareholders of record as of the close of business on March 22, 2019, which is the record date, are entitled to notice of and to vote at the Annual Meeting.
|
|
Q.
|
What is the quorum for the Annual Meeting?
|
|
A.
|
The presence at the Annual Meeting, in person or by proxy, of a majority of the votes entitled to be cast by the holders of all outstanding common shares of beneficial interest, $0.01 par value per share, of the Company, or "Common Shares," will constitute a quorum for the transaction of business. No business may be conducted at the meeting if a quorum is not present. As of the record date, 12,467,103 Common Shares were issued and outstanding. If less than a majority of our outstanding Common Shares entitled to vote are represented, in person or by proxy, at the Annual Meeting, the chairman of the meeting may adjourn or postpone the Annual Meeting to another date, time or place, not later than 120 days after the original record date of March 22, 2019. If a Common Share is deemed present at the Annual Meeting for any matter, it will be deemed present for all other matters. Pursuant to Maryland law, abstentions are treated as present for quorum purposes.
|
|
Q.
|
How many votes do I have?
|
|
A.
|
You are entitled to one vote for each whole Common Share you held as of the record date. Our shareholders do not have the right to cumulate their votes for trustees.
|
|
Q.
|
How do I vote my shares prior to the Annual Meeting?
|
|
A.
|
If you are a shareholder of record, meaning that your Common Shares are registered in your name, you have three voting options. You may vote:
|
|
Q.
|
Can I vote my shares during the Annual Meeting?
|
|
A.
|
You may vote your shares during the Annual Meeting by visiting www.virtualshareholdermeeting.com/EARN2019 and following the instructions. You will need the 16-digit control number included in your proxy card, voting instruction form or Notice of Availability. You will be able to vote during the Annual Meeting until such time as the Chairman declares the polls closed.
|
|
Q.
|
How do I vote my Common Shares that are held by my broker?
|
|
A.
|
If you hold your Common Shares in "street name" through an account with a broker or bank, you may instruct your broker or bank to vote your Common Shares or revoke your voting instructions by following the instructions that the broker provides to you. Most brokers allow you to authorize your proxy by mail and on the Internet.
|
|
Q.
|
What am I voting on?
|
|
A.
|
You will be voting on:
|
|
Q.
|
What vote is required to approve the proposals assuming that a quorum is present at the Annual Meeting?
|
|
Proposal
|
|
Vote Requirement
|
|
Proposal 1: Election of Trustees
|
|
A plurality of the votes cast for the election of each trustee nominee. The seven nominees who receive the most votes will be elected.
|
|
Proposal 2: An Advisory (Non-Binding) "Say on Pay" Vote to Approve Executive Compensation
|
|
The affirmative vote of a majority of the votes cast at the Annual Meeting. Voting for Proposal 2 is being conducted on an advisory basis and, therefore, the voting results will not be binding on the Company, the Board of Directors or the Compensation Committee.
|
|
Proposal 3: An Advisory (Non-Binding) Vote on the Frequency of Future Advisory "Say on Pay" Votes
|
|
A plurality of the votes cast for a frequency option (one, two or three years). Voting for Proposal 3 is being conducted on an advisory basis and, therefore, the voting results will not be binding on the Company, the Board of Directors or the Compensation Committee.
|
|
Proposal 4: Ratification of Appointment of Our Independent Registered Public Accounting Firm for 2019
|
|
The affirmative vote of a majority of the votes cast on this matter.
|
|
Proposal
|
|
Treatment of Abstentions and Broker Non-Votes
|
|
Proposal 1: Election of Trustees
|
|
Abstentions and Common Shares not represented at the Annual Meeting will have no effect on the election of trustees. Brokers are not entitled to vote on trustee elections and thus broker non-votes are not treated as votes cast and will have no effect on the election of trustees.
|
|
Proposal 2: An Advisory (Non-Binding) "Say on Pay" Vote to Approve Executive Compensation
|
|
Abstentions, broker non-votes and Common Shares not otherwise represented at the meeting are not treated as votes cast and will have no effect on the outcome of this proposal
|
|
Proposal 3: An Advisory (Non-Binding) Vote on the Frequency of Future Advisory "Say on Pay" Votes
|
|
Abstentions, broker non-votes and Common Shares not otherwise represented at the meeting are not treated as votes cast and will have no effect on the outcome of this proposal
|
|
Proposal 4: Ratification of Appointment of Our Independent Registered Public Accounting Firm for 2019
|
|
Pursuant to Maryland law, abstentions and broker non-votes are not included in the determination of the Common Shares voting on such matters, but are counted for quorum purposes.
Because this is considered a routine matter under NYSE rules, broker non-votes will not arise in connection with, and thus will have no effect on, this proposal.
|
|
Q.
|
Will there be any other items of business on the agenda?
|
|
A.
|
The Board of Trustees does not know of any other matters that may be brought before the Annual Meeting nor does it foresee or have reason to believe that proxy holders will have to vote for substitute or alternate nominees for election to the Board of Trustees. In the event that any other matter should come before the Annual Meeting or any nominee is not available for election, the persons named in the enclosed proxy will have discretionary authority to vote all proxies with respect to such matters in accordance with their discretion.
|
|
Q.
|
What happens if I submit my proxy without providing voting instructions on one or more proposals?
|
|
A.
|
Proxies properly submitted will be voted at the Annual Meeting in accordance with your directions. If the properly submitted proxy does not provide voting instructions on a proposal, the proxy will be voted, except in the case of a broker non-vote, to elect (FOR) each of the trustee nominees listed in "Proposal 1—Election of Trustees," in favor of (FOR) "Proposal 2—An Advisory (Non-Binding) ‘Say on Pay' Vote to Approve Executive Compensation," in favor of a vote annually for "Proposal 3—An Advisory (Non-Binding) Vote on the Frequency of Future Advisory ‘Say on Pay' Votes," and in favor of (FOR) "Proposal 4—Ratification of the Appointment of Independent Registered Public Accounting Firm for 2019."
|
|
Q.
|
Will anyone contact me regarding this vote?
|
|
A.
|
No arrangements or contracts have been made with any solicitors as of the date of this Proxy Statement, although we reserve the right to engage solicitors if we deem them necessary. Solicitations may be made by mail, telephone, facsimile, e-mail, or personal interviews.
|
|
Q.
|
Who will pay for this proxy solicitation?
|
|
A.
|
We will pay the entire expense of preparing, printing, and mailing the proxy materials and any additional materials furnished to shareholders. Proxies may be solicited by our trustees and officers and certain employees of EMG personally or by telephone without additional compensation for such activities. We also will request persons, firms, and corporations holding Common Shares in their names or in the names of their nominees, which are beneficially owned by others, to send appropriate solicitation materials to such beneficial owners. We will reimburse such holders for their reasonable expenses.
|
|
Q.
|
May shareholders ask questions at the Annual Meeting?
|
|
A.
|
Yes. You may vote and submit questions while attending the meeting online. You will need the sixteen-digit control number included on your Notice of Internet Availability of Proxy Materials, your proxy card or on the instructions that accompanied your proxy materials in order to be able to enter the meeting.
|
|
Q.
|
What does it mean if I receive more than one proxy card?
|
|
A.
|
It probably means your Common Shares are registered differently and are in more than one account. Sign and return all proxy cards, or vote by the methods provided by your broker to ensure that all your Common Shares are voted.
|
|
Q.
|
Can I change my vote after I have voted?
|
|
A.
|
Yes. A shareholder may revoke a proxy at any time prior to its exercise by filing with our Secretary a duly executed revocation of proxy, by properly submitting by mail a proxy to our Secretary bearing a later date or by attending the meeting online and voting. Attendance at the meeting will not by itself constitute revocation of a proxy.
|
|
Q.
|
Can I find additional information on the Company's website?
|
|
A.
|
Yes. Our Internet website is located at www.earnreit.com. Although the information contained on our website is not part of this Proxy Statement, you can view additional information on the website, such as our Corporate Governance Guidelines, our Code of Business Conduct and Ethics, charters of the committees of our Board and reports that we file with the Securities and Exchange Commission, or "SEC."
|
|
Name and Position
With Our Company
|
|
Age
|
|
Background Summary
|
|
Thomas F. Robards
Chairman of the Board
|
|
72
|
|
Mr. Robards has served as our Chairman since May 2013. Mr. Robards has been a principal in Robards & Co, LLC, a private investment and advisory company since July 2005. He currently serves as Chairman of the Board of Trustees and is a member of the Audit Committee of the HSBC Funds, a mutual fund complex. He currently serves as Chairman of the Board of Ellington Financial Inc., a NYSE-listed company that is externally managed by an affiliate of EMG, a position he has held since October 2009, and as Chairman of its Audit Committee, a position he has held since August 2007. He previously was a Director and Audit Committee Chair of Overseas Shipholding Group, Inc. from April 2005 until August 2014, and until December of 2006 was a Director and on the Audit Committee of Financial Federal Corporation, both NYSE-listed companies. From 2003 to 2004, he was the Senior Vice President and Chief Financial Officer of the American Museum of Natural History in New York, New York. He was the Chief Financial Officer for Datek Online Holding Corporation from 2000 until its acquisition by Ameritrade in 2002. Prior to that, Mr. Robards was employed at Republic New York Corporation for 24 years, including as Chief Financial Officer and Executive Vice President, and from 1997 to 1999 served on its Board of Directors. During his tenure his responsibilities at Republic included leading its Asset/Liability and Finance Committees as well as managing Republic National Bank treasury and investment portfolio activities. Mr. Robards earned his B.A. from Brown University and an M.B.A. from Harvard Business School.
Our Board believes that Mr. Robards' expertise in finance and accounting, including knowledge of financial institutions, public accounting, internal controls, audit committee performance and governance matters, and experience amassed from past and current service on the audit committees of NYSE-listed companies, give him the qualifications and skills to serve as a trustee of our Company. |
|
|
|
|
|
|
|
Michael W. Vranos
Co-Chief Investment Officer & Trustee
|
|
57
|
|
Mr. Vranos has been our Co-Chief Investment Officer since October 2012 and a member of our Board of Trustees since our inception in 2012. Mr. Vranos is also the Chief Executive Officer and President of our Manager. Mr. Vranos also serves as Co-Chief Investment Officer of Ellington Financial Inc. Mr. Vranos is also the founder and Chief Executive Officer of EMG, which he founded in December of 1994 to capitalize on distressed conditions in the mortgage-backed securities, or "MBS," derivatives market. Until December 1994, he was the Senior Managing Director of Kidder Peabody, in charge of residential mortgage-backed securities, or "RMBS," trading. Mr. Vranos graduated magna cum laude, Phi Beta Kappa with a B.A. in Mathematics from Harvard University.
Our Board believes that Mr. Vranos' operational experience as Co-Chief Investment Officer of our Company, trading and market expertise and, in particular, his extensive experience in the mortgage securities business, give him the qualifications and skills to serve as a trustee of our Company. |
|
Name and Position
With Our Company
|
|
Age
|
|
Background Summary
|
|
Laurence Penn
Chief Executive Officer, President & Trustee
|
|
57
|
|
Mr. Penn has been our Chief Executive Officer and President since October 2012 and has served as a member of our Board since our inception in 2012. Mr. Penn is also a Vice Chairman of EMG, where he helps oversee many functions of the firm. Mr. Penn is also the Executive Vice President of our Manager and serves on EMG's Investment and Risk Management Committee. Mr. Penn also serves as Chief Executive Officer, President, and a member of the Board of Directors of Ellington Financial Inc. Mr. Penn has also served as a Trustee of Ellington Income Opportunities Fund, a closed-end management investment company, since October 2018. In EMG's earlier years, Mr. Penn was the senior portfolio manager primarily responsible for investments in Agency RMBS. Prior to joining EMG in 1995 shortly after its inception, Mr. Penn was at Lehman Brothers where he was a Managing Director and co-head of CMO origination and trading. Mr. Penn began his career at Lehman Brothers in 1984, after receiving a Master of Advanced Study in Mathematics from Cambridge University, where he studied as both a National Science Foundation and Winston Churchill Scholar. Mr. Penn graduated summa cum laude, Phi Beta Kappa with a B.A. in Mathematics from Harvard University in 1983. He was one of five winners nationwide in the 1980 Putnam collegiate mathematics problem solving competition, and represented the United States in the 21st International Mathematics Olympiad held in London, England.
Our Board believes that Mr. Penn's operational experience as President and Chief Executive Officer of our Company, risk management and trading expertise and, in particular, his extensive experience in the mortgage securities business, give him the qualifications and skills to serve as a trustee of our Company. |
|
|
|
|
|
|
|
Ronald I. Simon, Ph.D.
Trustee
|
|
80
|
|
Dr. Simon has served as a member of our Board since May 2013. Dr. Simon has served as a member of the Board of Directors of Ellington Financial Inc. since 2007. Dr. Simon is a private investor and financial consultant to businesses. From March 2003 through February 2006, when it was acquired by Wachovia Corp., Dr. Simon was a Director of WFS Financial, Inc., a publicly-traded financial services company specializing in automobile finance. He was a director of Collateral Therapeutics from 1998 until its acquisition by Schering A.G. in 2002. From January 2006 to January 2009, he was a director of Cardium Therapeutics, a company formed to acquire and carry on the research and development of gene therapy to treat heart disease, which was originally developed by Collateral Therapeutics and then continued by Schering. From 1995 through 2002, Dr. Simon was a director of SoftNet Systems, Inc., and from 2002 through August 2016 he was a director of its successor company, American Independence Corp., a holding company engaged principally in the health insurance and reinsurance business. Since August 2016, Dr. Simon has served as a director, and since November 2017, as a member of the Audit Committee, of Independence Holdings Company, a holding company principally engaged in the life and health insurance business, and the successor company to American Independence Corp. He was a director of BDI Investment Corporation, a closely held regulated investment company, from February 2003 until its liquidation in early 2005, and served as Chief Financial Officer for Wingcast, LLC, a developer of automotive telematics, from 2001 to 2002. During 2001, Dr. Simon served as Acting Chairman, Chief Executive Officer and Chief Financial Officer for SoftNet Systems, Inc. He also served as Executive Vice President and Chief Financial Officer of Western Water Company from 1997 to 2000, and a director of Western Water Company from 1999 through 2001. Dr. Simon earned a B.A. from Harvard University, an M.A. from Columbia University, and a Ph.D. from Columbia University Graduate School of Business.
Our Board believes that Dr. Simon's expertise in finance and his extensive service in senior officer positions and directorships of public companies in a variety of industries give him the qualifications and skills to serve as a trustee of our Company. |
|
|
|
|
|
|
|
Name and Position
With Our Company
|
|
Age
|
|
Background Summary
|
|
|
|
|
|
|
|
Robert B. Allardice, III
Trustee
|
|
72
|
|
Mr. Allardice has served as a member of our Board since May 2013. Mr. Allardice is also a director, member of the audit committee, and chairman of the finance, investment and risk management committee of The Hartford Financial Services Group, Inc. (NYSE: HIG), where he has served since September 2008. Mr. Allardice has also served as a director of GasLog Partners LP (NYSE: GLOP) since October 2014. Mr. Allardice retired in 1999 from his position as regional chief executive officer of Deutsche Bank Americas Holding Corporation, North and South America, or "DBAHC." Prior to joining Deutsche Bank, Mr. Allardice was a consultant to Smith Barney. Prior to consulting to Smith Barney, Mr. Allardice spent nearly 20 years in positions of increasing responsibility at Morgan Stanley & Co., Inc. He founded the company's Merger Arbitrage Department and later became Chief Operating Officer of the Equity Department. Mr. Allardice has served as a board member of Bankers Trust Company, Carlyle Capital Corporation Ltd., DBAHC and Worldwide Excellerated Leasing Limited. Mr. Allardice earned a B.A. from Yale University and an MBA from Harvard University.
Our Board of Trustees believes that Mr. Allardice's more than 35 years of experience in the financial services industry, especially his experience as a senior executive officer engaged in strategic planning, risk management, talent development, financial management and financial reporting, and his service on the audit committee of an NYSE-listed company gives him the qualifications and skills to serve as a trustee of our Company. |
|
|
|
|
|
|
|
David J. Miller
Trustee
|
|
59
|
|
Mr. Miller serves as Chairman of the Board of J.G. Wentworth, a position he has held since February 2018. Mr. Miller previously served as the Chief Executive Officer of JGWPT Holdings, LLC, or "JGWPT," from January 2009 until July 2014 and was previously Chief Executive Officer of J.G. Wentworth, LLC, JGWPT's predecessor. In May 2009, J.G. Wentworth, LLC filed for bankruptcy protection under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court, District of Delaware. From May 2015 until January 2018, Mr. Miller served as a Senior Advisor to the Tactical Opportunties Group at Blackstone. He has served as a member of our Board since May 2013. Prior to joining J.G. Wentworth, LLC, in January 2009, Mr. Miller operated his own insurance consulting business. Prior to that, he was Executive Vice-President responsible for Ace Group's, or "Ace," International Accident and Health Insurance Business. Prior to his employment at Ace, Mr. Miller was President and Chief Executive Officer of Kemper Auto and Home Insurance, a joint venture between Mr. Miller and Kemper Insurance Company, which sells auto and homeowner's insurance via direct response and the internet. Before Kemper Auto and Home Insurance, Mr. Miller was Chief Operating Officer of Providian Direct Insurance. Mr. Miller began his insurance career with Progressive Insurance where he held various positions over his seven-year career including Division Controller, Senior Product Manager and National Customer Manager. Mr. Miller has a BSEE in electrical engineering from Duke University and a MBA in Finance from The Wharton School of the University of Pennsylvania. He was previously a member of the New York Stock Exchange.
Our Board of Trustees believes that Mr. Miller's financial and management expertise and his valuable experience gained from his tenure as an executive and as a director of other companies in the financial services industry gives him the qualifications and skills to serve as a trustee of our Company. |
|
|
|
|
|
|
|
Menes O. Chee
Trustee
|
|
41
|
|
Mr. Chee has served as a member of our Board since May 2013. Mr. Chee is a Senior Managing Director in the Tactical Opportunities Group at Blackstone. Mr. Chee joined Blackstone in 2009, as a Managing Director of GSO Capital Partners, and transferred to Tactical Opportunities in 2012. Before joining Blackstone, from 2005 until 2009, Mr. Chee was a Principal with TPG-Axon Capital, a global multi-strategy hedge fund manager. Prior to that, from 2003 until 2005, Mr. Chee was a private equity investment professional with Texas Pacific Group. Previous to Texas Pacific Group, from 1999 until 2003, Mr. Chee worked at Credit Suisse First Boston in the Merchant Banking Group and at Donaldson Lufkin & Jenrette in the Leveraged Finance Group. Mr. Chee graduated magna cum laude from the University of Pennsylvania with a B.S. in Economics from the Wharton School and a B.A. from the College, where he was elected to Phi Beta Kappa.
Our Board of Trustees believes that Mr. Chee's operational experience as a Senior Managing Director in the Tactical Opportunities Group at Blackstone and GSO Capital Partners, together with his experience as a Principal with TPG-Axon give him the qualifications and skills to serve as a trustee of our Company.
|
|
|
2018
|
|
2017
|
||||
|
Audit Fees
|
$
|
445,400
|
|
|
$
|
446,540
|
|
|
Audit-related Fees
|
—
|
|
|
—
|
|
||
|
Tax Fees
|
—
|
|
|
—
|
|
||
|
All Other Fees
|
909
|
|
|
909
|
|
||
|
Total Fees
|
$
|
446,309
|
|
|
$
|
447,449
|
|
|
1.
|
A trustee who is, or who has been within the last three years, an employee of our Company or any of its affiliates, or whose immediate family member is, or has been within the last three years, an executive officer of our Company or any of its affiliates.
|
|
2.
|
A trustee who has received or who has an immediate family member, serving as an executive officer, who has received, during any twelve-month period within the last three years, more than $120,000 in direct compensation from our Company (excluding trustee and committee fees, and pension/other forms of deferred compensation for prior service that is not contingent in any way on continued service).
|
|
3.
|
(A) A trustee who is or whose immediate family member is a current partner of a firm that is our internal or external auditor; (B) a trustee who is a current employee of such a firm; (C) a trustee who has an immediate family member who is a current employee of such a firm and who personally works on our audit; or (D) a trustee who was or whose immediate family member was within the last three years (but is no longer) a partner or employee of such a firm and personally worked on our audit within that time.
|
|
4.
|
A trustee who is or has been within the last three years, or whose immediate family member is, or has been within the last three years, employed as an executive officer of another company where any of our present executives at the same time serves or served on that company's compensation committee.
|
|
5.
|
A trustee who is a current employee, or whose immediate family member is a current executive officer, of a company that has made payments to, or received payments from, us for property or services in an amount which, in any of the last three fiscal years, exceeds the greater of $1 million or 2% of such other company's consolidated gross revenues (as reported for the last completed fiscal year).
|
|
Trustee Name
|
|
Audit
Committee
|
|
Compensation
Committee
|
|
Nominating and
Corporate
Governance
Committee
|
|
Robert B. Allardice, III
|
|
Chair
|
|
Member
|
|
Member
|
|
David J. Miller
|
|
Member
|
|
Chair
|
|
Member
|
|
Thomas F. Robards
|
|
Member
|
|
Member
|
|
Member
|
|
Ronald I. Simon, Ph.D.
|
|
Member
|
|
Member
|
|
Chair
|
|
Number of Meetings in 2018
|
|
7
|
|
6
|
|
3
|
|
•
|
honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
|
|
•
|
compliance with applicable governmental laws, rules, and regulations;
|
|
•
|
prompt internal reporting of violations of the code to appropriate persons identified in the Code of Business Conduct and Ethics; and
|
|
•
|
accountability for adherence to the Code of Business Conduct and Ethics.
|
|
Name
|
|
Fees Earned
or Paid in Cash
|
|
Restricted Common Share Awards
(1)
|
|
All Other Compensation
(2)
|
|
Total Compensation
|
|||||||||
|
Robert B. Allardice, III
|
|
$
|
73,000
|
|
|
$
|
39,000
|
|
(3)
|
|
$
|
3,985
|
|
|
$
|
115,985
|
|
|
David J. Miller
|
|
65,500
|
|
|
39,000
|
|
(4)
|
|
3,985
|
|
|
108,485
|
|
||||
|
Thomas F. Robards
|
|
83,000
|
|
|
39,000
|
|
(5)
|
|
3,985
|
|
|
125,985
|
|
||||
|
Ronald I. Simon, Ph.D.
|
|
65,500
|
|
|
39,000
|
|
(6)
|
|
3,985
|
|
|
108,485
|
|
||||
|
Menes O. Chee
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
||||
|
Laurence Penn
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
||||
|
Michael W. Vranos
|
|
—
|
|
|
—
|
|
|
|
—
|
|
|
—
|
|
||||
|
(1)
|
All share-based awards were granted pursuant to our 2013 Equity Incentive Plan. The aggregate grant date fair value was calculated in accordance with the Financial Accounting Standards Board's or "FASB," Accounting Standards Codification, or "ASC," Topic 718 based on the closing sale price for our Common Shares on the NYSE on the date of grant.
|
|
(2)
|
Amounts represent dividends paid on unvested restricted Common Share awards in 2018.
|
|
(3)
|
Mr. Allardice received 3,286 restricted Common Shares with a grant date fair value of $39,000. These restricted Common Shares were granted on September 12, 2018 and will vest, subject to certain limitations, on September 11, 2019.
|
|
(4)
|
Mr. Miller received 3,286 restricted Common Shares with a grant date fair value of $39,000. These restricted Common Shares were granted on September 12, 2018 and will vest, subject to certain limitations, on September 11, 2019.
|
|
(5)
|
Mr. Robards received 3,286 restricted Common Shares with a grant date fair value of $39,000. These restricted Common Shares were granted on September 12, 2018 and will vest, subject to certain limitations, on September 11, 2019.
|
|
(6)
|
Dr. Simon received 3,286 restricted Common Shares with a grant date fair value of $39,000. These restricted Common Shares were granted on September 12, 2018 and will vest, subject to certain limitations, on September 11, 2019.
|
|
•
|
Cross Transactions
—defined as transactions between us or one of our subsidiaries, on the one hand, and an account (other than us or one of our subsidiaries) managed by EMG or our Manager, on the other hand. It is EMG policy to engage in a cross transaction only when the transaction is in the best interests of, and is consistent with the objectives and policies of, both accounts involved in the transaction. EMG or our Manager may enter into cross transactions where it acts both on our behalf and on behalf of the other party to the transaction. Upon written notice to our Manager, we may at any time revoke our consent to our Manager's executing cross transactions. Additionally, unless approved in advance by a majority of our independent trustees or pursuant to and in accordance with a policy that has been approved by a majority of our independent trustees, all cross transactions must be effected at the then-prevailing market prices. Pursuant to our Manager's current policies and procedures, assets for which there are no readily observable market prices may be purchased or sold in cross transactions (1) at prices based upon third party bids received through auction, (2) at the average of the highest bid and lowest offer quoted by third party dealers, or (3) according to another pricing methodology approved by our Manager's Chief Compliance Officer.
|
|
•
|
Principal Transactions
—defined as transactions between EMG or our Manager (or any related party of EMG or our Manager, which includes employees of EMG and our Manager and their families), on the one hand, and us or one of our subsidiaries, on the other hand. Certain cross transactions may also be considered principal transactions whenever our Manager, EMG (or any related party of EMG or our Manager, which includes employees of EMG and our Manager and their families) have a substantial ownership interest in one of the transacting parties. Our Manager is only authorized to execute principal transactions with the prior approval of a majority of our independent trustees and in accordance with applicable law. Such prior approval includes approval of the pricing methodology to be used, including with respect to assets for which there are no readily observable market prices.
|
|
•
|
Investment in other EMG accounts
—pursuant to our management agreement, although we have not done so to date, if we invest at issuance in the equity of any collateralized debt obligation, or "CDO," that is managed, structured or originated by EMG or one of its affiliates, or if we invest in any other investment fund or other investment for which EMG or one of its affiliates receives management, origination or structuring fees, then, unless agreed otherwise by a majority of the Company's independent trustees, the base management fees payable by us to our Manager will be reduced by an amount equal to the applicable portion (as described in the management agreement) of any such management fees, origination fees or structuring fees.
|
|
•
|
Split price executions
—pursuant to our management agreement, our Manager is authorized to combine purchase or sale orders on our behalf together with orders for other accounts managed by EMG, our Manager or their affiliates and allocate the securities or other assets so purchased or sold, on an average price basis or other fair and consistent basis, among such accounts.
|
|
Name and Position
With Our Company
|
|
Age
|
|
Background Summary
|
|
Laurence Penn
Chief Executive Officer, President & Trustee
|
|
57
|
|
See "Proposal 1: Election of Trustees—Information Regarding the Nominees."
|
|
|
|
|
|
|
|
Michael W. Vranos
Co-Chief Investment Officer & Trustee
|
|
57
|
|
See "Proposal 1: Election of Trustees—Information Regarding the Nominees."
|
|
|
|
|
|
|
|
Mark Tecotzky
Co-Chief Investment Officer
|
|
57
|
|
Mr. Tecotzky has been our Co-Chief Investment Officer since October 2012 and the Co-Chief Investment Officer of Ellington Financial Inc. since March 2008. Mr. Tecotzky is also a Managing Director of EMG, and head portfolio manager for all MBS/ABS credit, reporting directly to Mr. Vranos. Prior to joining EMG in July 2006, Mr. Tecotzky was the senior trader in the mortgage department at Credit Suisse. He developed and launched several of its securitization vehicles, including hybrid adjustable-rate mortgages, or "ARMs," and second liens, and subsequently ran its hybrid ARM business, including conduit pricing, servicing sales, monthly securitization, trading of Agency/non-Agency hybrids of all ratings categories and managing and hedging the residual portfolio. Prior to joining Credit Suisse, Mr. Tecotzky worked with Mr. Vranos and many of the other EMG principals at Kidder Peabody, and traded Agency and non-Agency pass-throughs and structured CMOs as a Managing Director. Mr. Tecotzky holds a B.S. from Yale University, and received a National Science Foundation fellowship to study at MIT.
|
|
|
|
|
|
|
|
Christopher Smernoff
Chief Financial Officer
|
|
42
|
|
Mr. Smernoff joined EMG in January 2007 and has served as our Chief Financial Officer since April 2018. Mr. Smernoff also served as our Controller from April 2013 to April 2018. Mr. Smernoff is responsible for managing all aspects of our finance and accounting operations. In addition, Mr. Smernoff has served as the Chief Accounting Officer of EMG’s other public company affiliate, Ellington Financial Inc. (NYSE: EFC) since April 2018. Prior to that Mr. Smernoff served as EFC’s Controller since February 2010. From January 2007 through February 2010, Mr. Smernoff was an Assistant Controller for various private entities managed by EMG. Prior to January 2007, Mr. Smernoff was employed as a manager in the assurance practice of PricewaterhouseCoopers LLP, where he was primarily focused on providing audit and accounting services to a variety of clients in the investment management industry. Mr. Smernoff is a member of the American Institute of Certified Public Accountants and holds a B.S. in Accounting and Finance from Boston College.
|
|
|
|
|
|
|
|
JR Herlihy
Chief Operating Officer
|
|
37
|
|
Mr. Herlihy joined EMG in April 2011 and has served as our Chief Operating Officer since April 2018 and as our Treasurer since May 2017. In addition, Mr. Herlihy has been the Chief Financial Officer of Ellington Financial Inc. (NYSE: EFC) since April 2018 and its Treasurer since May 2017. Mr. Herlihy is also a Director at EMG, where he has served in various capacities, including serving as Co-Chief Investment Officer of our former affiliate, Ellington Housing Inc. (“EHR”), a real estate investment trust that was focused on single- and multi-family residential real estate assets, from EHR’s inception in September 2012 through December 2016. Mr. Herlihy also served as EHR’s Interim Chief Financial Officer from March 2015 through January 2016. Prior to April 2011, Mr. Herlihy held various positions in the real estate industry, including at the real estate private equity firm GTIS Partners LP, Capmark Financial Group (formerly GMAC Commercial Mortgage), and Jones Lang LaSalle. Mr. Herlihy earned a B.A. in Economics and History from Dartmouth College, summa cum laude and Phi Beta Kappa.
|
|
|
|
|
|
|
|
Daniel Margolis
General Counsel
|
|
44
|
|
Mr. Margolis has been our General Counsel since April 2013 and also served as our Secretary from inception to April 2013. Mr. Margolis has also served as General Counsel of EMG and of Ellington Financial Inc. since July 2010. He is responsible for advising EMG on all legal, regulatory, compliance, documentation and litigation matters. Prior to joining EMG, Mr. Margolis was a Partner at Pillsbury, Winthrop, Shaw, Pittman LLP from 2007 to 2010 and before that was a Junior Partner at Wilmer, Cutler, Pickering, Hale and Dorr LLP from 2004 to 2007. In both positions, Mr. Margolis represented corporations and individuals, including financial services organizations, in criminal and regulatory investigations and in complex civil litigation. From 2000 to 2004, he served as an Assistant United States Attorney in the United States Attorney's Office for the Southern District of New York where he prosecuted a variety of white collar crimes including securities fraud, investment fraud, tax fraud and money laundering. In 2004, he received the John Marshall Award, the Department of Justice's highest award for excellence in legal performance. He has a J.D. from New York University Law School, where he graduated cum laude, and a B.A. from Binghamton University where he graduated magna cum laude with highest honors in Political Science and was a member of Phi Beta Kappa.
|
|
Name and Principal Position
|
|
Year
|
|
Salary
(1)
|
|
Bonus
(2)
|
|
Stock Awards
|
|
All Other Compensation
(6)
|
|
Total
|
|||||||||||
|
Christopher Smernoff
Chief Financial Officer (7) |
|
2018
|
|
$
|
40,000
|
|
|
$
|
33,400
|
|
|
$
|
26,610
|
|
(3)
|
|
$
|
1,253
|
|
|
$
|
101,263
|
|
|
JR Herlihy
Chief Operating Officer (8) |
|
2018
|
|
$
|
41,600
|
|
|
$
|
43,680
|
|
|
$
|
43,688
|
|
(4)
|
|
$
|
—
|
|
|
$
|
128,968
|
|
|
Lisa Mumford
Former Chief Financial Officer
(9)
|
|
2018
|
|
$
|
12,500
|
|
|
$
|
28,080
|
|
|
$
|
—
|
|
|
|
$
|
7,582
|
|
|
$
|
48,162
|
|
|
|
|
2017
|
|
$
|
52,000
|
|
|
$
|
85,280
|
|
|
$
|
45,765
|
|
(5)
|
|
$
|
8,755
|
|
|
$
|
191,800
|
|
|
(1)
|
Reflects the pro rata portion of the executive officer's base salary that we were required to reimburse to the Manager. For Ms. Mumford in 2018 this reflects the period from January 1, 2018 through March 30, 2018.
|
|
(2)
|
Reflects the pro rata portion of the executive officer's bonus that we were required to reimburse to the Manager. A percentage of such bonuses is subject to deferral. For Ms. Mumford in 2018, this reflects the deferred portion of her bonus from 2017. As previously disclosed, we are party to a Retirement Agreement with Ms. Mumford, pursuant to which her deferred compensation will continue to vest according to schedule, and in return she will make herself available to provide reasonable assistance to our Company during such vesting period.
|
|
(3)
|
Mr. Smernoff received 2,359 restricted Common Shares with a grant date fair value of $26,610. These restricted Common Shares were granted on December 11, 2018, subject to forfeiture restrictions. The forfeiture restrictions on 1,180 of these Common Shares will lapse, subject to certain limitations, on December 11, 2019, and the forfeiture restrictions on the remaining 1,179 Common Shares will lapse, subject to certain limitations, on December 11, 2020. The aggregate grant date fair value was calculated in accordance with FASB ASC Topic 718 based on the closing sale price for our Common Shares on the NYSE on the date of grant.
|
|
(4)
|
Mr. Herlihy received 3,873 restricted Common Shares with a grant date fair value of $43,688. These restricted Common Shares were granted on December 11, 2018, subject to forfeiture restrictions. The forfeiture restrictions on 1,937 of these Common Shares will lapse, subject to certain limitations, on December 11, 2019, and the forfeiture restrictions on the remaining 1,936 Common Shares will lapse, subject to certain limitations, on December 11, 2020. The aggregate grant date fair value was calculated in accordance with FASB ASC Topic 718 based on the closing sale price for our Common Shares on the NYSE on the date of grant.
|
|
(5)
|
Ms. Mumford received 3,567 restricted Common Shares with a grant date fair value of $45,765. These restricted Common Shares were granted on December 12, 2017, subject to forfeiture restrictions. The forfeiture restrictions on 1,784 of these Common Shares lapsed on December 12, 2018, and the forfeiture restrictions on the remaining 1,783 Common Shares will lapse, subject to certain limitations, on December 12, 2019. The aggregate grant date fair value was calculated in accordance with FASB ASC Topic 718 based on the closing sale price for our Common Shares on the NYSE on the date of grant. As previously disclosed, we are party to a Retirement Agreement with Ms. Mumford, pursuant to which her deferred compensation will continue to vest according to schedule, and in return she will make herself available to provide reasonable assistance to our Company during such vesting period.
|
|
(6)
|
Amounts represent dividends paid on unvested restricted Common Share awards in each respective year.
|
|
(7)
|
Mr. Smernoff was appointed as our Chief Financial Officer on March 30, 2018.
|
|
(8)
|
Mr. Herlihy was appointed as our Chief Operating Officer on March 30, 2018.
|
|
(9)
|
Ms. Mumford retired as our Chief Financial Officer on March 30, 2018.
|
|
•
|
retain and motivate our partially dedicated Chief Financial Officer and our partially dedicated Chief Operating Officer by providing fair compensation;
|
|
•
|
encourage share ownership by providing a portion of compensation through restricted Common Shares; and
|
|
•
|
align management incentives with the long-term interests of our shareholders.
|
|
|
|
Stock Awards
|
||||
|
Name
|
|
Number of Common Shares
That Have Not Vested
|
|
Market Value of Common Shares That Have Not Vested
(1)
|
||
|
Christopher Smernoff
(2)
|
|
2,359
|
|
$
|
24,133
|
|
|
JR Herlihy
(3)
|
|
3,873
|
|
$
|
39,621
|
|
|
Lisa Mumford
(4)
|
|
1,783
|
|
$
|
18,241
|
|
|
(1)
|
Value is determined by multiplying the number of unvested restricted Common Shares by $10.23, the closing price for our Common Shares on the NYSE on December 31, 2018.
|
|
(2)
|
The restricted Common Shares are subject to forfeiture prior to December 11, 2019 in the case of 1,180 Common Shares, December 11, 2020 in the case of 1,179 Common Shares.
|
|
(3)
|
The restricted Common Shares are subject to forfeiture prior to December 11, 2019 in the case of 1,937 Common Shares, December 11, 2020 in the case of 1,936 Common Shares.
|
|
(4)
|
The restricted Common Shares are subject to forfeiture prior to December 12, 2019. As previously disclosed, we are party to a Retirement Agreement with Ms. Mumford, pursuant to which the forfeiture restrictions on her restricted Common Shares will lapse according to schedule, and in return she will make herself available to provide reasonable assistance to our Company during such period.
|
|
Plan Category
|
|
Number of securities to be issued upon exercise of outstanding options, warrants and rights (a)
|
|
Weighted-average exercise price of our outstanding options, warrants and rights (b)
|
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) (c)
|
||
|
Equity compensation plans approved by security holders
|
|
21,159
|
(1)
|
|
N/A
|
|
321,085
|
(2)
|
|
(1)
|
There are 21,159 restricted common shares outstanding pursuant to our 2013 Equity Incentive Plan.
|
|
(2)
|
The number of common shares that may be issued under the 2013 Equity Incentive Plan will be increased in an amount that results from multiplying 3% and the total number of common shares sold in any future public or private offering of our common shares, subject to a maximum of 1,500,000 shares.
|
|
•
|
all Common Shares the investor actually owns beneficially or of record;
|
|
•
|
all Common Shares over which the investor has or shares voting or dispositive control (such as in the capacity as a general partner of a fund); and
|
|
•
|
all Common Shares the investor has the right to acquire within 60 days of March 1, 2019 (such as upon exercise of options that are currently vested or which are scheduled to vest within 60 days).
|
|
|
|
Common Shares Beneficially Owned
|
||||
|
Name and Address
|
|
Number
|
|
Percentage of
Outstanding
Common Shares
(1)
|
||
|
5% Shareholders:
|
|
|
|
|
||
|
Blackstone
(2)
|
|
3,103,257
|
|
|
24.9
|
%
|
|
Renaissance Technologies LLC
(3)
|
|
925,000
|
|
|
7.4
|
%
|
|
The Vanguard Group
(4)
|
|
694,259
|
|
|
5.6
|
%
|
|
Trustees and Named Executive Officers:
(5)
|
|
|
|
|
||
|
Michael W. Vranos
(6)
|
|
160,912
|
|
|
1.3
|
%
|
|
Laurence E. Penn
|
|
35,710
|
|
|
*
|
|
|
Robert B. Allardice, III
(7)
|
|
14,525
|
|
|
*
|
|
|
Menes O. Chee
|
|
—
|
|
|
*
|
|
|
David J. Miller
(8)
|
|
24,525
|
|
|
*
|
|
|
Thomas Robards
(9)
|
|
14,525
|
|
|
*
|
|
|
Ronald I. Simon, Ph.D.
(10)
|
|
28,286
|
|
|
*
|
|
|
Christopher Smernoff
(11)
|
|
4,937
|
|
|
*
|
|
|
JR Herlihy
(12)
|
|
3,873
|
|
|
*
|
|
|
All executive officers and trustees as a group (11 persons)
(13)
|
|
295,575
|
|
|
2.4
|
%
|
|
(1)
|
Based on an aggregate amount of 13,203,828 Common Shares issued and outstanding as of March 1, 2019. Assumes that derivative securities, if any, beneficially owned by a person are exercised for Common Shares. The total number of Common Shares outstanding used in calculating this percentage assumes that none of the derivative securities owned by other persons are exercised for Common Shares.
|
|
(2)
|
Derived from a Form 4 jointly filed with the SEC on November 26, 2018, by Blackstone Tactical Opportunities EARN Holdings L.L.C., or "EARN Holdings," BTO EARN Manager L.L.C., BTOA L.L.C., Blackstone Holdings III L.P., Blackstone Holdings III GP L.P., Blackstone Holdings III GP Management L.L.C., The Blackstone Group L.P., Blackstone Group Management L.L.C. and Stephen A. Schwarzman. EARN Holdings directly holds 3,103,257 Common Shares. BTO EARN Manager L.L.C. is the managing member of EARN Holdings. BTOA L.L.C. is the sole member of BTO EARN Manager L.L.C. Blackstone Holdings III L.P. is the managing member of BTOA L.L.C. The general partner of Blackstone Holdings III L.P. is Blackstone Holdings III GP L.P. The general partner of Blackstone Holdings III GP L.P. is Blackstone Holdings III GP Management L.L.C. The sole member of Blackstone Holdings III GP Management L.L.C. is The Blackstone Group L.P. The general partner of The Blackstone Group L.P. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman. Each reporting entity has shared voting and dispositive power over 3,103,257 Common Shares. The address for Blackstone is 345 Park Avenue, New York, New York 10154.
|
|
(3)
|
Derived from a Schedule 13G/A jointly filed with the SEC on February 12, 2019. Renaissance Technologies LLC, or "RTC," and Renaissance Technologies Holdings Corporation, or "RTHC," jointly filed the Schedule 13G pursuant to a Joint Filing Agreement and collectively report that they may be deemed to beneficially own 925,000 Common Shares. EACH of RTC and RTHC has sole voting power over 925,000 Common Shares and sole dispositive power over 925,000 Common Shares. The address for RTC and RTHC is 800 Third Avenue, New York, New York 10022.
|
|
(4)
|
Derived from a Schedule 13G jointly filed witht he SEC on February 11, 2019. Vanguard Fiduciary Trust Company ("VFTC"), a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 2,110 shares or .01% of the Common Shares of the Company as a result of its serving as investment manager of collective trust accounts. The Vanguard Group has sole voting power over 2,110 Common Shares shares, sole dispositive power over 692,149 Common Shares, and shared dispositive power over 2,110 Common Shares.
|
|
(5)
|
The address for all named executive officers and trustees is Ellington Residential Mortgage REIT, 53 Forest Avenue, Old Greenwich, CT 06870.
|
|
(6)
|
Includes 127,779 Common Shares held directly by EMG Holdings, L.P., or "EMGH." VC Investments L.L.C., or "VC," and Michael W. Vranos each has shared voting and dispositive power over these Common Shares. VC is the general partner of EMGH. Mr. Vranos is the managing member of, and holds a controlling interest in VC. The address for each entity is 53 Forest Avenue, Old Greenwich, CT 06870.
|
|
(7)
|
Includes 3,286 Common Shares that will vest on September 11, 2019.
|
|
(8)
|
Includes 3,286 Common Shares that will vest on September 11, 2019. Mr. Miller holds 10,000 of these Common Shares in a joint account with his spouse.
|
|
(9)
|
Includes 3,286 Common Shares that will vest on September 11, 2019.
|
|
(10)
|
Includes 3,286 Common Shares that will vest on September 11, 2019.
|
|
(11)
|
Includes 1,180 Common Shares that will vest on December 11, 2019 and 1,179 that will vest on December 11, 2020.
|
|
(12)
|
Includes 1,937 Common Shares that will vest on December 11, 2019 and 1,936 that will vest on December 11, 2020.
|
|
(13)
|
Includes 13,144 Common Shares that will vest on September 11, 2019, 3,117 Common Shares that will vest on December 11, 2019, and 3,115 Common Shares that will vest on December 11, 2020.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|